NuScale Power Stock Is Down 20%. Is It Finally Time to Buy?

NuScale became the first U.S. company to win NRC approval for its small modular reactor design, but it still has no first customer and remains pre-commercial. The company is advancing projects in Romania and with TVA, while talks with South Korea may be progressing, yet Q1 revenue was only about $565,000 versus a net loss of about $44 million. The setup is strategically positive over the long term, but near-term execution and commercialization risk remain high.

Analysis

The key market signal is not that SMR has regulatory legitimacy; it is that the monetization path is still gated by project finance, not technology. In capital-intensive infrastructure, first revenue matters less than repeatability: until one plant is financed, built, and commissioned on budget, NuScale remains a prototype story trading on optionality rather than contracted cash flow. That makes the stock highly sensitive to any delay between “interest” and signed order, because each quarter of slippage extends dilution risk and keeps the company in a negative carry state.

The second-order beneficiary set is broader than the article implies. If SMR deployment becomes credible, the winners are less likely to be the reactor vendor itself and more likely to be the equipment, construction, and services stack that gets paid regardless of ultimate power economics. That favors industrials and nuclear-adjacent suppliers with backlog visibility over pure-play developers; the market will eventually price in that the bottleneck is execution and permitting, not demand for clean baseload power. Conversely, any failed commercialization attempt would likely compress multiples across the entire SMR cohort, not just SMR, because it would reinforce the view that first-of-a-kind nuclear projects remain financeable only with quasi-sovereign support.

The contrarian takeaway is that AI power demand is a real tailwind, but it may be overcredited to a single solution. Data-center operators need speed, modularity, and certainty; in the next 12-24 months, gas peakers, grid interconnects, and behind-the-meter solutions are more likely to absorb incremental demand than a first-of-a-kind nuclear build. The market may be extrapolating a structural AI power bottleneck into near-term SMR orders faster than customers can clear procurement, insurance, and construction hurdles.

Key Decisions for Investors

• Avoid initiating a standalone long in SMR ahead of a binding customer/financing announcement; the setup is dominated by dilution and project-delay risk over the next 1-3 quarters.
• For investors who want AI power exposure, prefer a basket long in grid/utility-enablement names over SMR-specific risk; use a 6-12 month horizon and favor names with contracted revenue and lower execution risk.
• Consider a pair trade: long nuclear-adjacent industrial/supply-chain beneficiaries, short SMR, to express the view that commercialization risk is underappreciated while infrastructure spending still flows. Hold through catalyst windows and trim if SMR converts talk into signed financing.
• If SMR rallies on partnership headlines without a funded EPC structure, fade strength via short-dated puts or a call spread, since the market is likely to overprice announcement risk relative to actual cash conversion.